LMNA-Related Dilated Cardiomyopathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which LMNA-Related Dilated Cardiomyopathy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05394506

Modifying Factors in Striated Muscle Laminopathies

Mutations in the LMNA gene, which codes for lamins A and C, proteins of the nuclear lamina, are responsible for a wide spectrum of pathologies, including a grou…

France40 participantsStarted 2022-09-08

Treatment: Skin Biopsy, Muscle biopsy

All recent trials (3 shown)

CompletedPhase 2

NCT02351856

A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

This is a rollover study designed to investigate the safety and effectiveness of investigational study drug ARRY-371797 in patients who previously received ARRY…

United States8 participantsStarted 2015-02-02

Treatment: ARRY-371797, p38 inhibitor, oral

CompletedPhase 2

NCT02057341

A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

This is a Phase 2 pilot study, involving a 48-week treatment period, designed to test the effectiveness of investigational study drug ARRY-371797 in treating pa…

United States12 participantsStarted 2014-02

Treatment: ARRY-371797, p38 inhibitor; oral